Search

Your search keyword '"Gillespie, G. Yancey"' showing total 603 results

Search Constraints

Start Over You searched for: Author "Gillespie, G. Yancey" Remove constraint Author: "Gillespie, G. Yancey"
603 results on '"Gillespie, G. Yancey"'

Search Results

1. Failure of human rhombic lip differentiation underlies medulloblastoma formation

2. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

3. Intertumoral Heterogeneity within Medulloblastoma Subgroups

4. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors

5. Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation

15. Subgroup-specific structural variation across 1,000 medulloblastoma genomes.

17. List of Contributors

27. Figure S7 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers

28. Data from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers

29. Supplementary Figure from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

30. Data from MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma

32. Supplementary Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

33. Supplementary Figure 2 from MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma

34. Supplementary Methods and Figure Legends from MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma

35. Supplementary Figure 1 from MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma

36. Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

37. Supplementary Figure 4 from MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma

38. Supplementary Figure 3 from MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma

40. N-cadherin upregulation mediates adaptive radioresistance in glioblastoma

41. Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma

42. Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers

43. An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases

47. Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

48. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study

Catalog

Books, media, physical & digital resources